The global Sjogren’s syndrome market is anticipated to grow at a significant CAGR of 4.6% during the forecast period. Sjogren’s syndrome is a disorder of the human immune system whereby it affects the parts of the body that produces fluids such as saliva, and tears. It’s a long-term condition that affects one’s daily life and is more common in women than men which usually starts at age 40 to 60. Sjogren also affects the other parts of the body such as kidneys, joints, lungs, nerves, and blood vessels. The treatment focuses on relieving the symptoms such as fiving artificial tears for dry eyes, sucking sugar-free candies, and drinking gallons of water for dry mouth along with taking some medicines. The factors contributing to the market growth include a growing population with several diseases that can cause Sjogren’s syndrome and increasing demand for advanced treatment for Sjogren’s syndrome.
Get Free Sample link @ https://www.omrglobal.com/request-sample/sjogrens-syndrome-market
However, a lack of awareness among the population about Sjogren’s syndrome restrains the growth of the market. Further lack of proper cure treatments is also projected to hamper the growth of the market. Currently, available treatment options are either ineffective in patients with the following syndrome or only relieve the symptoms. Increasing lab automation rates and technological advances will bring opportunities for the growth of the market.
A full report of Global Sjogren Syndrome Market available @ https://www.omrglobal.com/industry-reports/sjogrens-syndrome-market
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Sjogren’s Syndrome Market by Type
- Primary Sjögren’s Syndrome
- Secondary Sjögren’s Syndrome
Global Sjogren’s Syndrome Market by Drug Type
- Pilocarpine
- Cyclosporine
- Hydroxychloroquine
- Immunosuppressive Agents
Global Sjogren’s Syndrome Market by Test
- Blood Test
- Eye Test
- Imaging Test
- Biopsy
Regional Analysis
- North America
- US
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- AbbVie Inc.
- Amgen Inc.
- Argentis Pharmaceuticals, LLC
- AstraZeneca
- Aldeyra Therapeutics, Inc.
- Bristol-Myers Squibb Co.
- Biogen Inc.
- Demcon Hemics BV.
- Daiichi Sankyo Co., Ltd.
- Eisai Co., Ltd.
- Hoffmann-La Roche Ltd.
- Gilead Sciences, Inc.
- Horizon Therapeutics
- Johnson and Johnson Service Inc.
- Novartis International AG
- Otsuka Pharmaceutical Co., Ltd.
- ONO PHARMACEUTICAL CO., LTD
- Pfizer Inc.
- RemeGen, Ltd.
- Sanofi S.A
- Sun Pharmaceutical Industries Ltd.
- TearSolutions
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Sjogren’s syndrome market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/sjogrens-syndrome-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
